Contact

A lymphatic waste-disposal system implicated in Alzheimer’s disease

The discovery that a set of lymphatic vessels interacts with blood vessels to remove toxic waste products from the brain has implications for cognition, ageing and disorders such as Alzheimer’s disease has been reported.

Read more...

EATRIS ANNOUNCES NOVEL PUBLIC-PRIVATE COLLABORATION FOR IMAGING METHOD DEVELOPMENT IN INFLAMMATORY DISEASES

International multi-site collaboration hub will implement new clinical imaging tools and deliver several projects per year with enhanced speed and throughput

Amsterdam, The Netherlands, June 4, 2018 -  The European Infrastructure for Translational Medicine (EATRIS) has formed a collaboration with GlaxoSmithKline (GSK) to deliver a clinical and scientific expert network for the development and application of innovative imaging methods for inflammatory diseases.

Read more...

iPEPS Biotech Startup Competition

The iPEPS innovation accelerator and Scientist.com are launching a call for biotech startups developing a novel therapeutic and/or diagnostic approach with a main focus on central nervous system (CNS) diseases (neuro-oncology, psychiatry, neurological disorders or preventive health).

Apply now until July 16th, and get awarded:

  • Up to 6 months office/lab spaces at iPEPS
  • Up to $10,000 in research services through Scientist.com marketplace (to be used within one year)
  • Consulting with experts in preclinical/clinical development to build out your TPP (target product profile).

The winner of this competition and the runner-up will be announced at the end of September and will benefit of iPEPS mentoring to fast track the development of their projects in one of the most thriving research and innovation ecosystem in Paris.

bandeau AAP iPEPS 2018

Maladie d’Alzheimer : un rôle protecteur des dégénérescences neurofibrillaires ?

​Les larges agrégats de protéines Tau observés dans les neurones des personnes atteintes de la maladie d’Alzheimer sont considérés comme étant au moins partiellement à l’origine de la maladie. Une étude conduite par des chercheurs de MIRCen (Institut de biologie François Jacob/CEA, NeurATRIS) suggère au contraire que ces dégénérescences neurofibrillaires (DNF) joueraient un rôle protecteur. 

Read more...